Stocks股票 / Health Care / DGX
DGX US listed · USD美股 · 美元
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil.Quest Diagnostics公司是一家美国临床实验室。《财富》500强公司,Quest在美国、波多黎各、墨西哥和巴西运营。
Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-07-21Earnings财务业绩
next report下次财报 2026-07-23Estimates being raised — 17 analysts预期上调 — 17 位分析师
Post-earnings drift: -9.6% (20d)财报后漂移:-9.6%(20日)
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | DGX | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(历史) | 23.00x | 28.59 | |
| P/B市净率 | 3.18x | 3.44 | |
| P/S市销率 | 2.07x | 2.97 | |
| Earnings yield盈利收益率 | 4.35% | 2.72 | |
| FCF yield自由现金流收益率 | 5.96% | 4.00 | |
| Shareholder yield股东收益率 | 3.52% | 1.89 | |
| EV/EBITDA企业价值/EBITDA | 13.20x | 18.18 | |
| P/FCF市值/自由现金流 | 16.79x | 22.08 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Options positioning期权持仓
as of last close截至上一收盘Market makers are net long gamma — price pinned near current level做市商净持有正伽玛,价格倾向于在当前水平附近震荡
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: -$25.4M net (0 buyers, 8 sellers)-$25.4M 净值(0 买家,8 卖家)
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Casdin Capital | B | Holding持有 | 0.7% | 2026-03-31 |
Signal history信号历史
engine events引擎事件Company profile公司档案
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil.Quest Diagnostics公司是一家美国临床实验室。《财富》500强公司,Quest在美国、波多黎各、墨西哥和巴西运营。
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(静态) | 23.0× | 28.6× | 65% |
| Price / Book市净率 | 3.2× | 3.4× | 54% |
| Price / Sales市销率 | 2.1× | 3.0× | 62% |
| EV / EBITDAEV/EBITDA | 13.2× | 18.2× | 73% |
| Earnings yield盈利收益率 | 4.3% | 2.7% | 74% |
| Free-cash-flow yield自由现金流收益率 | 8.3% | 5.5% | 80% |
| Shareholder yield股东综合回报率 | 3.5% | 1.9% | 69% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +0.1% | -0.9% |
| 1 Month近1月 | +6.9% | -0.6% |
| 3 Months近3月 | +1.3% | +5.4% |
| 6 Months近6月 | +13.0% | +8.6% |
| Year to date年初至今 | +20.6% | +8.9% |
| 1 Year近1年 | +26.1% | +19.2% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $9.4B | $10.8B | $9.9B | $9.3B | $9.9B | $11.0B |
| EPS每股收益 | $10.47 | $15.55 | $7.97 | $7.49 | $7.69 | $8.75 |
| Free cash flow自由现金流 | $1.6B | $1.8B | $1.3B | $864M | $909M | $1.4B |
| Gross margin毛利率 | 38.5% | 39.0% | 34.7% | 33.0% | 32.9% | 33.2% |
| Net margin净利率 | 15.2% | 18.5% | 9.6% | 9.2% | 8.8% | 9.0% |
| FCF margin自由现金流利润率 | 16.8% | 17.0% | 13.3% | 9.3% | 9.2% | 12.3% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量:应计利润接近同业中位
- Working capital: working capital roughly in line with sales营运资本:营运资本与销售大致同步
- Pricing power: gross margin −5.3pts over 6 years定价能力:毛利率 6 年下降 5.3 个百分点
- Capital discipline: investment near the peer median资本纪律:投资力度接近同业中位
- Balance sheet: Altman Z 3.38 — safe zone资产负债表:Altman Z 3.38——安全区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Estimate revisions预期修正
Dealer positioning map做市商持仓地图
Volatility pricing波动率定价
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Casdin Capital | B | Holding持有 | 0.7% | $10M |